Lai Ting (来婷)来婷
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂
药物知识说明
黄体酮是一种在国家药监局注册认定的药品。标注生产企业为浙江医药股份有限公司新昌制药厂。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂、浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂、浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 来婷) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 浙江医药股份有限公司新昌制药厂.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂, 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂, 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 来婷Recorded Chinese name: 来婷
- 剂型Dosage form: 丸剂Pills
- 规格Specification: 0.1g*6粒0.1 g × 6 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 浙江医药股份有限公司新昌制药厂Chinese legal name: 浙江医药股份有限公司新昌制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20040982
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20040982
Manufacturer
Chinese legal name: 浙江医药股份有限公司新昌制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.1 g × 6 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H20040982
生产企业
浙江医药股份有限公司新昌制药厂(国产)
适应症
用于治疗由黄体酮缺乏引起的机能障碍。排卵机能障碍引起的月经失调。痛经及经前期综合征。出血（由纤维瘤等所致）。绝经前紊乱。绝经（用于补充雌激素治疗）。本品也助于妊娠。在使用黄体酮进行治疗的所有适应症时，因黄体酮能引起诸如嗜睡，头晕目眩等不良反应时，可以用阴道给药代替口服给药。
用法用量
口服1．预防未切除子宫且正在服用结合雌激素的绝经期妇女的子宫内膜增生：在28天的月经周期中，每晚1次，每次200mg（2粒），连用12天。2．继发性闭经：每晚1次，每次400mg(4粒)，连用10天。
不良反应
突破性出血，阴道点状出血，体重增加或减少，宫颈鳞柱交界改变，宫颈分泌物性状改变，乳房肿胀，恶心，头晕，头痛，倦怠感，发热，失眠，过敏伴或不伴瘙痒的皮疹，黑斑病，黄褐斑，阻塞性黄疽，肝功能异常。
禁忌
有严重肝脏疾病者禁用，对本品中任何成分过敏者禁用。
注意事项
1.该药物不适用于治疗所有的自发性流产，尤其是对遗传因素造成的病症（占50%以上）无效。|2.妊娠过程中使用该产品时只能用到前3个月而且是采用阴道给药方式使用。因妊娠第4-9个月时服用本品会导致肝脏的不良反应。|3.按照规定使用本品无避孕作用。|4.口服给药，最好远隔进餐时间，最好晚上睡觉前服用。|5.服用该药物会分散汽车司机和机械师的注意力，尤其是口服给药后，会有困倦，嗜睡和头晕眼花的感觉。
贮藏
常温，密封保存。
规格
0.1g*6粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.